Status:
COMPLETED
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Otitis Media
Otitis Media With Effusion
Eligibility:
All Genders
6-24 years
Brief Summary
The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.
Eligibility Criteria
Inclusion
- Infants aged from 6 to 24 months
- Presenting with AOM (ear infection)
- Patients must not have received any antibiotic therapy within the past 7 days.
- Other inclusion applies.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
3293 Patients enrolled
Trial Details
Trial ID
NCT00195611
Start Date
September 1 2005
End Date
June 1 2006
Last Update
June 29 2010
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Auch, France, 32000
2
Brest, France, 29200
3
Canne La Boca, France, 06150
4
Chambéry, France, 73000